ASX:HLS Healius (HLS) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free HLS Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume2.33 million shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield4.46%Price TargetN/A Stock AnalysisStock Analysis Get Healius alerts: Email Address Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. About Healius Stock (ASX:HLS)Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.Read More Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. HLS Stock News HeadlinesMarch 28, 2024 | afr.comHealius in management shake-up after CEO exitMarch 17, 2024 | afr.comMaking excuses for weak margins has ended: Healius CEOApril 25, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.March 4, 2024 | marketwatch.comHealius Begins Strategic Review of Assets, Structure Under New CEOMarch 4, 2024 | fool.com.auBeaten-up ASX 200 stock jumps 14% on CEO resignationFebruary 27, 2024 | msn.comAustralia stocks higher at close of trade; S&P/ASX 200 up 0.13%November 29, 2023 | morningstar.comHealius Ltd HLSNovember 29, 2023 | fool.com.auHere's why you might have just bought Healius sharesApril 25, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.November 27, 2023 | fool.com.auHealius share price rallies amid corporate resetNovember 26, 2023 | au.investing.comASX 200 update: Healius Chairwoman Jenny Macdonald to retireNovember 22, 2023 | morningstar.com.auThis equity raise looks extremely attractiveNovember 21, 2023 | msn.comTop 10 at 11: Boardroom battles and spinning drills are driving the market this morningNovember 21, 2023 | fool.com.auWhy are Healius shares crashing 35% on Wednesday?November 20, 2023 | fool.com.auWhy weren't Healius shares trading on the ASX today?October 31, 2023 | afr.comHealius LimitedOctober 26, 2023 | msn.comAustralia stocks lower at close of trade; S&P/ASX 200 down 0.04%September 1, 2023 | msn.comScoPo’s Powerplays: ASX health stocks rise as big names ‘trading at very attractive fundamentals’August 30, 2023 | fool.com.auHealius share price rises strongly despite 92% profit crash in FY23May 25, 2023 | uk.finance.yahoo.comHLS.AX - Healius LimitedApril 17, 2023 | afr.comTakeovers Panel declines to adjudicate on hostile Healius takeoverApril 7, 2023 | finance.yahoo.comWith 58% ownership of the shares, Healius Limited (ASX:HLS) is heavily dominated by institutional ownersApril 4, 2023 | msn.com50% upside: The small-cap ASX share that has everything going for itMarch 26, 2023 | afr.comHealius slings ACL bid to Takeovers PanelMarch 26, 2023 | afr.comWylie’s Tanarra Capital spoils ACL’s Healius buyout hopesMarch 20, 2023 | finance.yahoo.comHealius (ASX:HLS) shareholders notch a 13% CAGR over 3 years, yet earnings have been shrinkingMarch 19, 2023 | msn.comHealius share price jumps 7% on takeover approach from smaller rivalSee More Headlines Receive HLS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Healius and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/15/2019Today4/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolASX:HLS CUSIPN/A CIKN/A Webwww.primaryhealthcare.com.au Phone61 2 9432 9400FaxN/AEmployees10,500Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($1.65) Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth-0.94Net Income$-984,100,000.00 Net Margins-57.63% Pretax MarginN/A Return on Equity-68.02% Return on Assets1.31% Debt Debt-to-Equity Ratio153.80 Current Ratio0.53 Quick Ratio0.47 Sales & Book Value Annual Sales$1.69 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow12.26 Book ValueA$1.45 per share Price / BookN/AMiscellaneous Outstanding Shares726,100,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.65 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Paul D. AndersonMD, Group CFO, CEO & DirectorMr. John McKechnieAdvisorDr. Jan Van RooyenHead & Group Executive of Healius PathologyDr. Phil LucasChief Executive of Lumus ImagingIan McphanChief Operating Officer of Healius PathologySharon NgHead of Group FP&AMs. Mary Ellen Weaver AGIACompany SecretaryDr. John HoustonAdvisorMore ExecutivesKey CompetitorsANGLEOTCMKTS:ANPCYAustralian Clinical LabsASX:ACLBARD1 Life SciencesASX:BD1BCAL DiagnosticsASX:BDXbioAffinity TechnologiesNASDAQ:BIAFWView All CompetitorsInsidersSally EvansBought 16,450 shares on 3/15/2024Total: $25,004.00 ($1.52/share)Maxine JaquetSold 512,645 sharesTotal: $1.50 M ($2.93/share)Maxine JaquetSold 1,667,805 sharesTotal: $2.33 M ($1.40/share)Charlie TaylorBought 50,000 shares on 12/21/2023Total: $74,500.00 ($1.49/share)Charlie TaylorBought 50,000 shares on 12/19/2023Total: $74,800.00 ($1.50/share) HLS Stock Analysis - Frequently Asked Questions How were Healius' earnings last quarter? Healius Limited (ASX:HLS) issued its earnings results on Friday, February, 15th. The company reported $0.04 EPS for the quarter, missing the consensus estimate of $0.09 by $0.06. Healius had a negative trailing twelve-month return on equity of 68.02% and a negative net margin of 57.63%. Is Healius a good dividend stock? Healius (ASX:HLS) pays an annual dividend of A$0.12 per share and currently has a dividend yield of 4.46%. HLS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for HLS. What other stocks do shareholders of Healius own? Based on aggregate information from My MarketBeat watchlists, some companies that other Healius investors own include BetaShares Crude Oil Index ETF Currency Hedged (Synthetic) (OOO), Neometals (NMT), Magellan High Conviction Trust (MHH), Helloworld Travel (HLO), Flight Centre Travel Group (FLT), Beach Energy (BPT), Bank of Queensland (BOQ), Australis Oil & Gas (ATS), ANZ Group (ANZ) and Aeris Environmental (AEI). This page (ASX:HLS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Healius Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
